Literature DB >> 12360555

Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson's disease.

Kin-Lun Tsang1, Iris Chi, Shu-Leong Ho, Vivian Weiqun Lou, Tatia M C Lee, Leung-Wing Chu.   

Abstract

PDQ-39 has been widely used in the research and clinical management of Parkinson's disease. It has been translated into and validated in various non-English languages. We report here on the validity and reliability results for the translated standard Chinese PDQ-39 questionnaire. Fifty-four patients were recruited from a movement disorder clinic and two regional patient groups, and data were collected by direct interview. Nineteen patients had the tests repeated 4 weeks later to assess the test-retest and interrater reliability. The standard Chinese version of PDQ-39 demonstrated acceptable internal consistency (Cronbach's alpha = 0.54-0.90) and was comparable to versions in other languages. Further analysis showed good construct validity and test-retest reliability. Implications and limitations of the study are discussed. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 12360555     DOI: 10.1002/mds.10249

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Health-related quality of life of australians with Parkinson disease: a comparison with international studies.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Meg E Morris
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

2.  Development and validation of the Chinese version of the Multicultural Quality of Life Index (MQLI-Ch).

Authors:  Jason S Liu; Juan E Mezzich; Maria I Zapata-Vega; Maria A Ruiperez; Gihyun Yoon
Journal:  Cult Med Psychiatry       Date:  2008-03

3.  Reliability and validity of PDQ-39: a quality-of-life measure for patients with PD in China.

Authors:  Jing-Lin Zhang; Piu Chan
Journal:  Qual Life Res       Date:  2011-10-09       Impact factor: 4.147

4.  Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Wei Luo; Xiao-hong Gui; Bo Wang; Wen-ying Zhang; Zhi-yuan Ouyang; Yi Guo; Bao-rong Zhang; Mei-ping Ding
Journal:  J Zhejiang Univ Sci B       Date:  2010-07       Impact factor: 3.066

5.  Considerations before initiating therapy in Parkinsonism: basing on the quality of life.

Authors:  Shu-Jin He; Zhen-Yang Liu; Yu-Jie Yang; Cong Shen; Yu-Jie Du; Xin-Yue Zhou; Jue Zhao; Yi-Min Sun; Ke Yang; Jian-Jun Wu; Feng-Tao Liu; Jian Wang
Journal:  J Neurol       Date:  2019-09-18       Impact factor: 4.849

6.  Chinese medicine for idiopathic Parkinson's disease: A meta analysis of randomized controlled trials.

Authors:  Wei Wei; Hai-Yong Chen; Wen Fan; Shui-Fen Ye; Yi-Hui Xu; Jing Cai
Journal:  Chin J Integr Med       Date:  2016-10-27       Impact factor: 1.978

7.  Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Hui-Ing Ma; Wen-Juh Hwang; Mei-Jin Chen-Sea
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

8.  Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Jojo Y Y Kwok; Jackie C Y Kwan; M Auyeung; Vincent C T Mok; Claire K Y Lau; K C Choi; Helen Y L Chan
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

9.  Quality of life in Parkinson's disease: Italian validation of the Parkinson's Disease Questionnaire (PDQ-39-IT).

Authors:  Giovanni Galeoto; Francesca Colalelli; Perla Massai; Anna Berardi; Marco Tofani; Mariangela Pierantozzi; Annamaria Servadio; Andrea Fabbrini; Giovanni Fabbrini
Journal:  Neurol Sci       Date:  2018-08-07       Impact factor: 3.307

10.  The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.

Authors:  Peter Hagell; Carita Nygren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.